J
The startup specializes in the identification and acquisition of neglected therapeutics from large pharmaceutical companies, transforming them into standalone biotech firms for commercialization. This approach addresses the significant gap in the market for novel therapies targeting large unmet medical needs.
Updated 3 months ago
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup specializes in the identification and acquisition of neglected therapeutics from large pharmaceutical companies, transforming them into standalone biotech firms for commercialization. This approach addresses the significant gap in the market for novel therapies targeting large unmet medical needs.